PLUS THERAPEUTICS, INC. — Director's Dealing 2017

May 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CTYX)
CIK: 0001095981
Period of Report: 2017-05-22

Reporting Person: LAPOINTE ANTHONY GREGG (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-22	Non-Qualified Stock Option (right to buy)	$1.60	A	50000	Acquired	2027-03-31	Common Stock (50000)	Direct

Footnotes

F1: The option grant was approved by the issuer's board of directors on March 31, 2017, subject to stockholder approval of the amendment and restatement of the issuer's 2014 Equity Incentive Plan (the "Restated Plan") under which the option was granted. The issuer's stockholders approved the Restated Plan on May 22, 2017.

F2: Fifty percent (50%) of the option shares shall vest on March 31, 2018 with the remaining fifty percent (50%) of the option shares vesting on March 31, 2019.